RxDoctor Payments Data

Richard Kettelkamp, DO

Interventional Cardiology · Cedar Rapids, IANPI 1922042894

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 56.2% of the total. Reporting peaked in 2019 at $1,441 and has fallen 92.4% since, to $110 in 2025. That places this record below the midpoint for interventional cardiology clinicians in IA, where the typical reported total is $3,872.

$2,161in general payments, 2019–2025

Across 49 payments — averaging $44.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$1K
  • Abbott$284
  • Medtronic$250
  • Edwards Lifesciences$170
  • Abiomed$70
  • Boston Scientific$45
  • plus $129 from 6 others

What the payments were for

  • Travel & lodging$1,20056%
  • Food & beverage$94344%
  • Education$181%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,161 in reported general payments places this provider in the 30th percentile of 64 interventional cardiology providers in Iowa.

See all interventional cardiology providers in Iowa

Medicare billing

Part B allowed, 2024
$236,824
Medicare patients
1,560
Services billed
3,117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban373$343,009
XareltoRivaroxaban230$204,895
Repatha SureclickEvolocumab156$92,696
EntrestoSacubitril/Valsartan54$51,125
BrilintaTicagrelor45$25,518
Metoprolol Succinate915$10,069
Atorvastatin Calcium581$4,357
ClopidogrelClopidogrel Bisulfate501$3,865
Potassium Chloride175$3,473
Diltiazem 24hr Er (Cd)Diltiazem Hcl188$3,170
Isosorbide Mononitrate ErIsosorbide Mononitrate224$3,152
Bumetanide52$3,071
Ezetimibe118$2,759
Rosuvastatin Calcium222$2,336
Ranolazine ErRanolazine22$2,149

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Cedar Rapids

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →